Sinopharm Tech Holdings Limited (HKSE: 8156.HK) Stock Competitors & Peer Comparison
See 8156.HK's competitors and their performance on the HKSE and across the wider stock market.
Peer Comparison Table: Software - Application Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for 8156.HK and its HKSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 8156.HK | HK$0.16 | +2.52% | 103.3M | -40.45 | -HK$0.00 | N/A |
| 2513.HK | HK$1,237.00 | +5.64% | 551.5B | -951.54 | -HK$1.30 | N/A |
| 89888.HK | HK$89.95 | -2.28% | 244.8B | -71.96 | -HK$1.25 | N/A |
| 6880.HK | HK$253.00 | -8.07% | 59.6B | N/A | N/A | N/A |
| 9660.HK | HK$4.42 | -3.28% | 55.4B | -5.11 | -HK$0.87 | N/A |
| 0020.HK | HK$1.32 | -5.04% | 52.8B | -24.16 | -HK$0.05 | N/A |
| 2723.HK | HK$549.00 | -0.18% | 49.8B | 4575.00 | HK$0.12 | N/A |
| 3888.HK | HK$23.98 | -1.72% | 32.5B | 10.64 | HK$2.25 | +0.54% |
| 0268.HK | HK$6.99 | -2.65% | 24.4B | 154.99 | HK$0.05 | N/A |
| 2026.HK | HK$56.10 | -1.23% | 24.3B | -37.99 | -HK$1.48 | N/A |
Stock Comparison
Knowledge Atlas Tech Joint (HKSE: 2513.HK)
8156.HK vs 2513.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2513.HK has a market cap of 551.5B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2513.HK trades at HK$1,237.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2513.HK's P/E ratio is -951.54. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2513.HK's ROE of +0.65%. Regarding short-term risk, 8156.HK is less volatile compared to 2513.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 2513.HK's competition here
Baidu, Inc. (HKSE: 89888.HK)
8156.HK vs 89888.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 89888.HK has a market cap of 244.8B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 89888.HK trades at HK$89.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 89888.HK's P/E ratio is -71.96. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 89888.HK's ROE of +0.00%. Regarding short-term risk, 8156.HK is more volatile compared to 89888.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 89888.HK's competition here
Momenta Global Ltd. Class A (HKSE: 6880.HK)
8156.HK vs 6880.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6880.HK has a market cap of 59.6B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6880.HK trades at HK$253.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6880.HK's P/E ratio is N/A. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6880.HK's ROE of +0.00%. Regarding short-term risk, 8156.HK is more volatile compared to 6880.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6880.HK's competition here
Horizon Robotics (HKSE: 9660.HK)
8156.HK vs 9660.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 9660.HK has a market cap of 55.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 9660.HK trades at HK$4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 9660.HK's P/E ratio is -5.11. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 9660.HK's ROE of -0.85%. Regarding short-term risk, 8156.HK is more volatile compared to 9660.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 9660.HK's competition here
SenseTime Group Inc. (HKSE: 0020.HK)
8156.HK vs 0020.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0020.HK has a market cap of 52.8B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0020.HK trades at HK$1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0020.HK's P/E ratio is -24.16. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0020.HK's ROE of -0.07%. Regarding short-term risk, 8156.HK is more volatile compared to 0020.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 0020.HK's competition here
Deepzero (HKSE: 2723.HK)
8156.HK vs 2723.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2723.HK has a market cap of 49.8B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2723.HK trades at HK$549.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2723.HK's P/E ratio is 4575.00. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2723.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 2723.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2723.HK's competition here
Kingsoft Corporation Limited (HKSE: 3888.HK)
8156.HK vs 3888.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 3888.HK has a market cap of 32.5B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 3888.HK trades at HK$23.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 3888.HK's P/E ratio is 10.64. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 3888.HK's ROE of +0.11%. Regarding short-term risk, 8156.HK is more volatile compared to 3888.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 3888.HK's competition here
Kingdee International Software Group Company Limited (HKSE: 0268.HK)
8156.HK vs 0268.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0268.HK has a market cap of 24.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0268.HK trades at HK$6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0268.HK's P/E ratio is 154.99. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0268.HK's ROE of +0.02%. Regarding short-term risk, 8156.HK is more volatile compared to 0268.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 0268.HK's competition here
Pony AI Inc. Class A (HKSE: 2026.HK)
8156.HK vs 2026.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2026.HK has a market cap of 24.3B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2026.HK trades at HK$56.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2026.HK's P/E ratio is -37.99. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2026.HK's ROE of -0.41%. Regarding short-term risk, 8156.HK is more volatile compared to 2026.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2026.HK's competition here
Beijing 51WORLD Digital Twin Technology Co., Ltd. (HKSE: 6651.HK)
8156.HK vs 6651.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6651.HK has a market cap of 22.3B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6651.HK trades at HK$55.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6651.HK's P/E ratio is -99.29. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6651.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 6651.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6651.HK's competition here
XD Inc. (HKSE: 2400.HK)
8156.HK vs 2400.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2400.HK has a market cap of 20B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2400.HK trades at HK$41.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2400.HK's P/E ratio is 12.39. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2400.HK's ROE of +0.45%. Regarding short-term risk, 8156.HK is more volatile compared to 2400.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2400.HK's competition here
PATEO CONNECT Technology (Shanghai) Corporation (HKSE: 2889.HK)
8156.HK vs 2889.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2889.HK has a market cap of 18.5B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2889.HK trades at HK$129.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2889.HK's P/E ratio is -14.58. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2889.HK's ROE of -0.61%. Regarding short-term risk, 8156.HK is more volatile compared to 2889.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2889.HK's competition here
Meitu, Inc (HKSE: 1357.HK)
8156.HK vs 1357.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1357.HK has a market cap of 17.8B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1357.HK trades at HK$3.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1357.HK's P/E ratio is 22.70. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1357.HK's ROE of +0.11%. Regarding short-term risk, 8156.HK is more volatile compared to 1357.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1357.HK's competition here
WeRide Inc. Class A (HKSE: 0800.HK)
8156.HK vs 0800.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0800.HK has a market cap of 14.6B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0800.HK trades at HK$14.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0800.HK's P/E ratio is -40.98. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0800.HK's ROE of -0.11%. Regarding short-term risk, 8156.HK is more volatile compared to 0800.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 0800.HK's competition here
Phancy Group Co., Ltd. (HKSE: 6682.HK)
8156.HK vs 6682.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6682.HK has a market cap of 13.3B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6682.HK trades at HK$26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6682.HK's P/E ratio is -42.56. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6682.HK's ROE of -0.00%. Regarding short-term risk, 8156.HK is more volatile compared to 6682.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6682.HK's competition here
Newborn Town Inc. (HKSE: 9911.HK)
8156.HK vs 9911.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 9911.HK has a market cap of 11.5B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 9911.HK trades at HK$8.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 9911.HK's P/E ratio is 22.64. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 9911.HK's ROE of +0.42%. Regarding short-term risk, 8156.HK is more volatile compared to 9911.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 9911.HK's competition here
Deepexi Technology Co Ltd (HKSE: 1384.HK)
8156.HK vs 1384.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1384.HK has a market cap of 11B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1384.HK trades at HK$32.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1384.HK's P/E ratio is -8.87. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1384.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 1384.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1384.HK's competition here
Marketingforce Management Ltd (HKSE: 2556.HK)
8156.HK vs 2556.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2556.HK has a market cap of 10.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2556.HK trades at HK$38.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2556.HK's P/E ratio is 100.18. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2556.HK's ROE of +0.05%. Regarding short-term risk, 8156.HK is more volatile compared to 2556.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2556.HK's competition here
UISEE Technologies (Beijing) Co., Ltd. Class H (HKSE: 1511.HK)
8156.HK vs 1511.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1511.HK has a market cap of 9.8B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1511.HK trades at HK$60.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1511.HK's P/E ratio is -37.64. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1511.HK's ROE of -0.44%. Regarding short-term risk, 8156.HK is more volatile compared to 1511.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1511.HK's competition here
Shanghai Able Digital Science&Tech Co., Ltd. (HKSE: 2687.HK)
8156.HK vs 2687.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2687.HK has a market cap of 9.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2687.HK trades at HK$151.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2687.HK's P/E ratio is 60.68. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2687.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 2687.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2687.HK's competition here
Shandong Extreme Vision Technology Co., Ltd. (HKSE: 6636.HK)
8156.HK vs 6636.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6636.HK has a market cap of 8.8B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6636.HK trades at HK$77.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6636.HK's P/E ratio is -165.74. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6636.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 6636.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6636.HK's competition here
CaoCao Inc. (HKSE: 2643.HK)
8156.HK vs 2643.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2643.HK has a market cap of 8.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2643.HK trades at HK$14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2643.HK's P/E ratio is -10.50. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2643.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 2643.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2643.HK's competition here
Reconova Technologies Co., Ltd. (HKSE: 7656.HK)
8156.HK vs 7656.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 7656.HK has a market cap of 8.1B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 7656.HK trades at HK$29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 7656.HK's P/E ratio is N/A. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 7656.HK's ROE of N/A. Regarding short-term risk, 8156.HK is less volatile compared to 7656.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 7656.HK's competition here
CiDi Inc. (HKSE: 3881.HK)
8156.HK vs 3881.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 3881.HK has a market cap of 7.7B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 3881.HK trades at HK$18.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 3881.HK's P/E ratio is -26.84. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 3881.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 3881.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 3881.HK's competition here
Vobile Group Limited (HKSE: 3738.HK)
8156.HK vs 3738.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 3738.HK has a market cap of 5.8B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 3738.HK trades at HK$2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 3738.HK's P/E ratio is 29.25. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 3738.HK's ROE of +0.07%. Regarding short-term risk, 8156.HK is more volatile compared to 3738.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 3738.HK's competition here
JST Group Corporation Limited (HKSE: 6687.HK)
8156.HK vs 6687.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6687.HK has a market cap of 5.3B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6687.HK trades at HK$12.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6687.HK's P/E ratio is -1.49. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6687.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 6687.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6687.HK's competition here
Youzan Technology Limited (HKSE: 8083.HK)
8156.HK vs 8083.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8083.HK has a market cap of 5.2B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8083.HK trades at HK$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8083.HK's P/E ratio is 16.20. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8083.HK's ROE of +0.14%. Regarding short-term risk, 8156.HK is more volatile compared to 8083.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8083.HK's competition here
Weimob Inc. (HKSE: 2013.HK)
8156.HK vs 2013.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2013.HK has a market cap of 4.7B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2013.HK trades at HK$1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2013.HK's P/E ratio is 600.00. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2013.HK's ROE of -0.10%. Regarding short-term risk, 8156.HK is more volatile compared to 2013.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2013.HK's competition here
Dmall Inc. (HKSE: 2586.HK)
8156.HK vs 2586.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2586.HK has a market cap of 4.6B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2586.HK trades at HK$5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2586.HK's P/E ratio is 60.80. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2586.HK's ROE of +0.18%. Regarding short-term risk, 8156.HK is more volatile compared to 2586.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2586.HK's competition here
Huitongda Network Co., Ltd. (HKSE: 9878.HK)
8156.HK vs 9878.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 9878.HK has a market cap of 4.1B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 9878.HK trades at HK$7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 9878.HK's P/E ratio is 12.58. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 9878.HK's ROE of +0.04%. Regarding short-term risk, 8156.HK is more volatile compared to 9878.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 9878.HK's competition here
Asiainfo Technologies Limited (HKSE: 1675.HK)
8156.HK vs 1675.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1675.HK has a market cap of 4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1675.HK trades at HK$4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1675.HK's P/E ratio is 9.58. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1675.HK's ROE of +0.02%. Regarding short-term risk, 8156.HK is more volatile compared to 1675.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1675.HK's competition here
Manycore Tech (HKSE: 0068.HK)
8156.HK vs 0068.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0068.HK has a market cap of 3.7B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0068.HK trades at HK$8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0068.HK's P/E ratio is -28.14. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0068.HK's ROE of -0.26%. Regarding short-term risk, 8156.HK is more volatile compared to 0068.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 0068.HK's competition here
Baiwang Co., Ltd. (HKSE: 6657.HK)
8156.HK vs 6657.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6657.HK has a market cap of 3.6B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6657.HK trades at HK$16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6657.HK's P/E ratio is -65.71. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6657.HK's ROE of -0.01%. Regarding short-term risk, 8156.HK is less volatile compared to 6657.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 6657.HK's competition here
Zhejiang Taimei Medical Technology Co., Ltd. (HKSE: 2576.HK)
8156.HK vs 2576.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2576.HK has a market cap of 3.2B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2576.HK trades at HK$5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2576.HK's P/E ratio is -128.91. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2576.HK's ROE of -0.02%. Regarding short-term risk, 8156.HK is more volatile compared to 2576.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2576.HK's competition here
Beisen Holding Ltd. (HKSE: 9669.HK)
8156.HK vs 9669.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 9669.HK has a market cap of 2.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 9669.HK trades at HK$3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 9669.HK's P/E ratio is -110.67. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 9669.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 9669.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 9669.HK's competition here
Ming Yuan Cloud Group Holdings Limited (HKSE: 0909.HK)
8156.HK vs 0909.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0909.HK has a market cap of 2.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0909.HK trades at HK$1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0909.HK's P/E ratio is -161.29. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0909.HK's ROE of +0.01%. Regarding short-term risk, 8156.HK is more volatile compared to 0909.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 0909.HK's competition here
International Business Digital Technology Limited (HKSE: 1782.HK)
8156.HK vs 1782.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1782.HK has a market cap of 2.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1782.HK trades at HK$2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1782.HK's P/E ratio is -28.01. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1782.HK's ROE of -0.29%. Regarding short-term risk, 8156.HK is more volatile compared to 1782.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1782.HK's competition here
YSB Inc. (HKSE: 9885.HK)
8156.HK vs 9885.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 9885.HK has a market cap of 2.3B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 9885.HK trades at HK$3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 9885.HK's P/E ratio is 24.73. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 9885.HK's ROE of +0.06%. Regarding short-term risk, 8156.HK is more volatile compared to 9885.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 9885.HK's competition here
Youzan Technology Ltd. (HKSE: 6051.HK)
8156.HK vs 6051.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6051.HK has a market cap of 2.1B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6051.HK trades at HK$1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6051.HK's P/E ratio is 128.00. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6051.HK's ROE of N/A. Regarding short-term risk, 8156.HK is more volatile compared to 6051.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6051.HK's competition here
Saimo (HKSE: 2571.HK)
8156.HK vs 2571.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2571.HK has a market cap of 2B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2571.HK trades at HK$15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2571.HK's P/E ratio is 30.00. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2571.HK's ROE of +0.06%. Regarding short-term risk, 8156.HK is more volatile compared to 2571.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2571.HK's competition here
Minieye Technology Co., Ltd (HKSE: 2431.HK)
8156.HK vs 2431.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2431.HK has a market cap of 1.7B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2431.HK trades at HK$5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2431.HK's P/E ratio is -4.52. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2431.HK's ROE of N/A. Regarding short-term risk, 8156.HK is less volatile compared to 2431.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 2431.HK's competition here
Chanjet Information Technology Company Limited (HKSE: 1588.HK)
8156.HK vs 1588.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1588.HK has a market cap of 1.4B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1588.HK trades at HK$4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1588.HK's P/E ratio is 17.15. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1588.HK's ROE of +0.09%. Regarding short-term risk, 8156.HK is more volatile compared to 1588.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1588.HK's competition here
Be Friends Holding Limited (HKSE: 1450.HK)
8156.HK vs 1450.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1450.HK has a market cap of 1.1B. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1450.HK trades at HK$0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1450.HK's P/E ratio is 17.25. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1450.HK's ROE of +0.18%. Regarding short-term risk, 8156.HK is more volatile compared to 1450.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1450.HK's competition here
Tradelink Electronic Commerce Limited (HKSE: 0536.HK)
8156.HK vs 0536.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0536.HK has a market cap of 915.5M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0536.HK trades at HK$1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0536.HK's P/E ratio is 10.87. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0536.HK's ROE of +0.22%. Regarding short-term risk, 8156.HK is more volatile compared to 0536.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 0536.HK's competition here
Founder Holdings Limited (HKSE: 0418.HK)
8156.HK vs 0418.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0418.HK has a market cap of 783.9M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0418.HK trades at HK$0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0418.HK's P/E ratio is 17.05. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0418.HK's ROE of +0.03%. Regarding short-term risk, 8156.HK is more volatile compared to 0418.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 0418.HK's competition here
Wuxi Life International Holdings Group Limited (HKSE: 8148.HK)
8156.HK vs 8148.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8148.HK has a market cap of 769.7M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8148.HK trades at HK$1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8148.HK's P/E ratio is 1680.00. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8148.HK's ROE of +0.19%. Regarding short-term risk, 8156.HK is more volatile compared to 8148.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8148.HK's competition here
Changjiu Holdings Limited (HKSE: 6959.HK)
8156.HK vs 6959.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6959.HK has a market cap of 728.7M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6959.HK trades at HK$3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6959.HK's P/E ratio is 4.51. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6959.HK's ROE of +0.30%. Regarding short-term risk, 8156.HK is more volatile compared to 6959.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6959.HK's competition here
Enterprise Development Holdings Limited (HKSE: 1808.HK)
8156.HK vs 1808.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1808.HK has a market cap of 590.2M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1808.HK trades at HK$2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1808.HK's P/E ratio is 3.57. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1808.HK's ROE of +0.33%. Regarding short-term risk, 8156.HK is more volatile compared to 1808.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1808.HK's competition here
Xuan Wu Cloud Technology Holdings Limited (HKSE: 2392.HK)
8156.HK vs 2392.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2392.HK has a market cap of 543.9M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2392.HK trades at HK$0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2392.HK's P/E ratio is -33.34. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2392.HK's ROE of -0.18%. Regarding short-term risk, 8156.HK is more volatile compared to 2392.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2392.HK's competition here
Anacle Systems Limited (HKSE: 8353.HK)
8156.HK vs 8353.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8353.HK has a market cap of 443.6M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8353.HK trades at HK$1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8353.HK's P/E ratio is 54.50. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8353.HK's ROE of +0.03%. Regarding short-term risk, 8156.HK is more volatile compared to 8353.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8353.HK's competition here
Sinosoft Technology Group Limited (HKSE: 1297.HK)
8156.HK vs 1297.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1297.HK has a market cap of 403.4M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1297.HK trades at HK$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1297.HK's P/E ratio is -1.74. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1297.HK's ROE of -0.08%. Regarding short-term risk, 8156.HK is more volatile compared to 1297.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1297.HK's competition here
Doumob (HKSE: 1917.HK)
8156.HK vs 1917.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1917.HK has a market cap of 211.6M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1917.HK trades at HK$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1917.HK's P/E ratio is -13.24. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1917.HK's ROE of -0.70%. Regarding short-term risk, 8156.HK is more volatile compared to 1917.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1917.HK's competition here
Shanghai Jiaoda Withub Information Industrial Company Limited (HKSE: 8205.HK)
8156.HK vs 8205.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8205.HK has a market cap of 187.2M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8205.HK trades at HK$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8205.HK's P/E ratio is -23.31. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8205.HK's ROE of -1.00%. Regarding short-term risk, 8156.HK is more volatile compared to 8205.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8205.HK's competition here
Newlink Technology Inc. (HKSE: 9600.HK)
8156.HK vs 9600.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 9600.HK has a market cap of 185.6M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 9600.HK trades at HK$0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 9600.HK's P/E ratio is -1.59. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 9600.HK's ROE of -0.31%. Regarding short-term risk, 8156.HK is less volatile compared to 9600.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 9600.HK's competition here
Qeeka Home (Cayman) Inc. (HKSE: 1739.HK)
8156.HK vs 1739.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1739.HK has a market cap of 175.3M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1739.HK trades at HK$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1739.HK's P/E ratio is -1.29. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1739.HK's ROE of -0.07%. Regarding short-term risk, 8156.HK is more volatile compared to 1739.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1739.HK's competition here
Famous Tech International Holdings Limited (HKSE: 8100.HK)
8156.HK vs 8100.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8100.HK has a market cap of 160M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8100.HK trades at HK$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8100.HK's P/E ratio is 74.69. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8100.HK's ROE of -0.03%. Regarding short-term risk, 8156.HK is less volatile compared to 8100.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 8100.HK's competition here
Duiba Group Limited (HKSE: 1753.HK)
8156.HK vs 1753.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1753.HK has a market cap of 156.1M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1753.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1753.HK's P/E ratio is -3.66. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1753.HK's ROE of -0.09%. Regarding short-term risk, 8156.HK is more volatile compared to 1753.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1753.HK's competition here
Novatech Intelligence Limited (HKSE: 8131.HK)
8156.HK vs 8131.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8131.HK has a market cap of 126.9M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8131.HK trades at HK$0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8131.HK's P/E ratio is -27.90. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8131.HK's ROE of +2.26%. Regarding short-term risk, 8156.HK is less volatile compared to 8131.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 8131.HK's competition here
Joy Spreader Group Inc. (HKSE: 6988.HK)
8156.HK vs 6988.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6988.HK has a market cap of 118.6M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6988.HK trades at HK$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6988.HK's P/E ratio is -0.11. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6988.HK's ROE of -0.36%. Regarding short-term risk, 8156.HK is more volatile compared to 6988.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6988.HK's competition here
Elephant Holdings Group Limited (HKSE: 8635.HK)
8156.HK vs 8635.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8635.HK has a market cap of 111.8M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8635.HK trades at HK$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8635.HK's P/E ratio is -4.62. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8635.HK's ROE of -0.01%. Regarding short-term risk, 8156.HK is more volatile compared to 8635.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8635.HK's competition here
OneForce Holdings Limited (HKSE: 1933.HK)
8156.HK vs 1933.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1933.HK has a market cap of 106.5M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1933.HK trades at HK$0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1933.HK's P/E ratio is -11.23. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1933.HK's ROE of -0.96%. Regarding short-term risk, 8156.HK is more volatile compared to 1933.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1933.HK's competition here
Lvji Technology Holdings Inc. (HKSE: 1745.HK)
8156.HK vs 1745.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 1745.HK has a market cap of 101.2M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 1745.HK trades at HK$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 1745.HK's P/E ratio is 0.75. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 1745.HK's ROE of +0.05%. Regarding short-term risk, 8156.HK is more volatile compared to 1745.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 1745.HK's competition here
China e-Wallet Payment Group Limited (HKSE: 0802.HK)
8156.HK vs 0802.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 0802.HK has a market cap of 92.9M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 0802.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 0802.HK's P/E ratio is -0.27. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 0802.HK's ROE of -1.92%. Regarding short-term risk, 8156.HK is less volatile compared to 0802.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 0802.HK's competition here
Flowing Cloud Technology Ltd (HKSE: 6610.HK)
8156.HK vs 6610.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 6610.HK has a market cap of 91M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 6610.HK trades at HK$0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 6610.HK's P/E ratio is -0.26. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 6610.HK's ROE of -0.30%. Regarding short-term risk, 8156.HK is more volatile compared to 6610.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 6610.HK's competition here
Ahsay Backup Software Development Company Limited (HKSE: 8290.HK)
8156.HK vs 8290.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8290.HK has a market cap of 76M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8290.HK trades at HK$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8290.HK's P/E ratio is -42.22. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8290.HK's ROE of +0.00%. Regarding short-term risk, 8156.HK is more volatile compared to 8290.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8290.HK's competition here
Digital Hollywood Interactive Limited (HKSE: 2022.HK)
8156.HK vs 2022.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 2022.HK has a market cap of 72.4M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 2022.HK trades at HK$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 2022.HK's P/E ratio is -3.87. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 2022.HK's ROE of -0.16%. Regarding short-term risk, 8156.HK is more volatile compared to 2022.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 2022.HK's competition here
eBroker Group Limited (HKSE: 8036.HK)
8156.HK vs 8036.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8036.HK has a market cap of 49.3M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8036.HK trades at HK$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8036.HK's P/E ratio is -33.08. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8036.HK's ROE of -0.10%. Regarding short-term risk, 8156.HK is more volatile compared to 8036.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8036.HK's competition here
China Netcom Technology Holdings Limited (HKSE: 8071.HK)
8156.HK vs 8071.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8071.HK has a market cap of 40.3M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8071.HK trades at HK$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8071.HK's P/E ratio is -5.06. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8071.HK's ROE of -0.78%. Regarding short-term risk, 8156.HK is more volatile compared to 8071.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8071.HK's competition here
Yu Tak International Holdings Limited (HKSE: 8048.HK)
8156.HK vs 8048.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8048.HK has a market cap of 35.1M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8048.HK trades at HK$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8048.HK's P/E ratio is -3.05. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8048.HK's ROE of -0.14%. Regarding short-term risk, 8156.HK is less volatile compared to 8048.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 8048.HK's competition here
Global Link Communications Holdings Limited (HKSE: 8060.HK)
8156.HK vs 8060.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8060.HK has a market cap of 31M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8060.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8060.HK's P/E ratio is -3.04. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8060.HK's ROE of +0.09%. Regarding short-term risk, 8156.HK is more volatile compared to 8060.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8060.HK's competition here
Finsoft Financial Investment Holdings Limited (HKSE: 8018.HK)
8156.HK vs 8018.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8018.HK has a market cap of 25.2M. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8018.HK trades at HK$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8018.HK's P/E ratio is -0.75. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8018.HK's ROE of -0.37%. Regarding short-term risk, 8156.HK is more volatile compared to 8018.HK. This indicates higher risk in terms of short-term price fluctuations for 8156.HK.Check 8018.HK's competition here
China Binary New Fintech Group (HKSE: 8255.HK)
8156.HK vs 8255.HK Comparison July 2026
Sinopharm Tech Holdings Limited (HKSE: 8156.HK) plays a significant role within the Technology sector. Its performance on the HKSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8156.HK stands at 103.3M. In comparison, 8255.HK has a market cap of 0. Regarding current trading prices, 8156.HK is priced at HK$0.16 on the HKSE, while 8255.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8156.HK currently has a P/E ratio of -40.45, whereas 8255.HK's P/E ratio is 5.62. In terms of profitability, 8156.HK's ROE is -0.08%, compared to 8255.HK's ROE of -1.55%. Regarding short-term risk, 8156.HK is less volatile compared to 8255.HK. This indicates lower risk in terms of short-term price fluctuations for 8156.HK.Check 8255.HK's competition here